Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.
Rejuvenation Technologies's investors include Y Combinator, Khosla Ventures, Longevitytech.fund, 99 Startups, Asymmetry Ventures.
Rejuvenation Technologies is headquartered in Mountain View, United States.
Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.
Rejuvenation Technologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rejuvenation Technologies — Funding & Investors." VCBacked, October 11, 2023, https://www.vcbacked.co/company/rejuvenation-technologies. Accessed July 27, 2026.
VCBacked. (2023). Rejuvenation Technologies — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/rejuvenation-technologies
{{cite web |title=Rejuvenation Technologies — Funding & Investors |url=https://www.vcbacked.co/company/rejuvenation-technologies |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated